Nuria Mulet

1.8k total citations
11 papers, 120 citations indexed

About

Nuria Mulet is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nuria Mulet has authored 11 papers receiving a total of 120 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nuria Mulet's work include Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Genetic factors in colorectal cancer (3 papers). Nuria Mulet is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Genetic factors in colorectal cancer (3 papers). Nuria Mulet collaborates with scholars based in Spain and Italy. Nuria Mulet's co-authors include Élena Elez, Guillem Argilés, Josep Tabernero, Javier Ros, Iosune Baraibar, Davide Ciardiello, Giulia Martini, Francesc Salvà, Rodrigo Dienstmann and Ignacio Matos and has published in prestigious journals such as Journal of Clinical Oncology, Expert Opinion on Investigational Drugs and Expert Opinion on Biological Therapy.

In The Last Decade

Nuria Mulet

11 papers receiving 117 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuria Mulet Spain 5 85 46 38 36 25 11 120
Abdelkader Seroutou Switzerland 5 96 1.1× 120 2.6× 36 0.9× 19 0.5× 30 1.2× 7 179
Claire Scudder United Kingdom 4 89 1.0× 30 0.7× 27 0.7× 29 0.8× 28 1.1× 7 121
Julieta Grasselli Spain 5 73 0.9× 45 1.0× 21 0.6× 19 0.5× 30 1.2× 11 106
María Elena Elez Spain 6 115 1.4× 50 1.1× 18 0.5× 59 1.6× 24 1.0× 10 167
Ariadna García Spain 6 84 1.0× 46 1.0× 44 1.2× 32 0.9× 56 2.2× 12 128
Wenhui Wu China 9 109 1.3× 89 1.9× 39 1.0× 48 1.3× 41 1.6× 17 189
Heather Estrella United States 4 165 1.9× 89 1.9× 112 2.9× 48 1.3× 58 2.3× 7 231
Inne HM Borel Rinkes Netherlands 7 83 1.0× 31 0.7× 18 0.5× 12 0.3× 28 1.1× 8 179
Luay Mousa United States 5 51 0.6× 38 0.8× 32 0.8× 14 0.4× 25 1.0× 9 117
Valentina Pomella Belgium 4 94 1.1× 26 0.6× 36 0.9× 34 0.9× 18 0.7× 7 100

Countries citing papers authored by Nuria Mulet

Since Specialization
Citations

This map shows the geographic impact of Nuria Mulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuria Mulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuria Mulet more than expected).

Fields of papers citing papers by Nuria Mulet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuria Mulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuria Mulet. The network helps show where Nuria Mulet may publish in the future.

Co-authorship network of co-authors of Nuria Mulet

This figure shows the co-authorship network connecting the top 25 collaborators of Nuria Mulet. A scholar is included among the top collaborators of Nuria Mulet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuria Mulet. Nuria Mulet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
González, Beatríz, et al.. (2025). KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials. npj Precision Oncology. 9(1). 380–380. 1 indexed citations
2.
Baraibar, Iosune, Francesc Salvà, R. Comas, et al.. (2021). Young-onset colorectal cancer: A call for action.. Journal of Clinical Oncology. 39(15_suppl). 10563–10563. 1 indexed citations
3.
Gonzalez, N. Saoudi, Francesc Salvà, Javier Ros, et al.. (2021). Up-to-date role of aflibercept in the treatment of colorectal cancer. Expert Opinion on Biological Therapy. 21(10). 1315–1324. 5 indexed citations
4.
Ros, Javier, Iosune Baraibar, Nuria Mulet, et al.. (2021). BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer. Therapeutic Advances in Medical Oncology. 13. 3864608014–3864608014. 48 indexed citations
5.
Baraibar, Iosune, Javier Ros, Nuria Mulet, et al.. (2020). Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update. Expert Review of Molecular Diagnostics. 20(7). 653–664. 12 indexed citations
6.
Martini, Giulia, Rodrigo Dienstmann, Javier Ros, et al.. (2020). Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer. Therapeutic Advances in Medical Oncology. 12. 3863551129–3863551129. 35 indexed citations
7.
Martini, Giulia, Iosune Baraibar, Guillermo Villacampa, et al.. (2020). Patient and tumor characteristics as determinants of overall survival (OS) in BRAF V600 mutant (mt) metastatic colorectal cancer (mCRC) treated with doublet or triplet targeted therapy.. Journal of Clinical Oncology. 38(15_suppl). 4112–4112. 4 indexed citations
8.
Matos, Ignacio, Javier Ros, Nuria Mulet, et al.. (2019). Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials. Expert Opinion on Investigational Drugs. 28(5). 463–471. 8 indexed citations
9.
Muro, Xavier García del, et al.. (2018). Combination of CDK and Bcl-2 inhibitors in the treatment of soft-tissue sarcomas.. Journal of Clinical Oncology. 36(15_suppl). 11582–11582. 1 indexed citations
10.
Mulet, Nuria, Ignacio Matos, Giulia Martini, et al.. (2018). Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer. Expert Opinion on Pharmacotherapy. 19(6). 623–629. 4 indexed citations
11.
Soler, G., Cristina Santos, Nuria Mulet, et al.. (2018). Colorectal surgery in the elderly: Does the extreme age determine the odds ratio of complications?. Journal of Clinical Oncology. 36(15_suppl). e22046–e22046. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdelkader Seroutou Breakdown of academic impact, for papers by Claire Scudder Breakdown of academic impact, for papers by Julieta Grasselli Breakdown of academic impact, for papers by María Elena Elez Breakdown of academic impact, for papers by Ariadna García Breakdown of academic impact, for papers by Wenhui Wu Breakdown of academic impact, for papers by Heather Estrella Breakdown of academic impact, for papers by Inne HM Borel Rinkes Breakdown of academic impact, for papers by Luay Mousa Breakdown of academic impact, for papers by Valentina Pomella
Rankless by CCL
2026